Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sisram MedicalSRAMF -87.41%87 Days Sales Outstanding is 82.38 as of Dec. 2025, which is 3% below its 10-year median of 84.68. GuruFocus rates SRAMF with a GF Score™ of 87/100 and a GF Value™ of $1.00 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Sisram Medical ranks worse than 75.83% on this metric.
Sisram Medical's average Accounts Receivable for the
six
months ended in Dec. 2025 was $90.2 Mil. Sisram Medical's Revenue for the
six
months ended in Dec. 2025 was $199.9 Mil.
Hence, Sisram Medical's Days Sales Outstanding for the
six
months ended in Dec. 2025 was 82.38.
The historical rank and industry rank for Sisram Medical's Days Sales Outstanding or its related term are showing as below:
SRAMF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 71.99 Med: 84.68 Max: 108.43
Current: 93.69
During the past 11 years, Sisram Medical's highest Days Sales Outstanding was 108.43. The lowest was 71.99. And the median was 84.68.
SRAMF's Days Sales Outstanding is ranked worse than 75.83% of 811
companies
in the Medical Devices & Instruments industry
Industry Median: 65.38
vs SRAMF: 93.69
Sisram Medical's Days Sales Outstanding
declined
from Dec. 2024 (86.19) to Dec. 2025 (82.38).
Sisram Medical (OTCPK:SRAMF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Sisram Medical Days Sales Outstanding Related Terms
Sisram Medical Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Sisram Medical's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SRAMF vs ABT, SYK, MDT: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Sisram Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sisram Medical Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Sisram Medical's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sisram Medical (SRAMF) has a Days Sales Outstanding of 82.38 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Sisram Medical and its competitors. This is near median its historical median of 84.68. Over the past decade, Sisram Medical's Days Sales Outstanding has ranged from 71.99 to 108.43. According to the industry distribution chart, Sisram Medical ranks #615 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 75.8%.
Is Sisram Medical's Days Sales Outstanding too high?
Sisram Medical's current Days Sales Outstanding of 82.38 is near median its 10-year median of 84.68. Over the past 10 years, this metric has ranged from a low of 71.99 to a high of 108.43. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.38. Sisram Medical's value of 82.38 is 26% above this industry median. Based on the distribution chart, Sisram Medical ranks #615 out of 811 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sisram Medical has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sisram Medical's Days Sales Outstanding compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sisram Medical ranks #615 out of 811 companies for Days Sales Outstanding. This places Sisram Medical in the lower half of its industry. The industry median Days Sales Outstanding is 65.38. Sisram Medical's value of 82.38 is 26% above this benchmark. Historically, Sisram Medical's own Days Sales Outstanding has ranged from 71.99 to 108.43 over the past decade. While the company's 10-year median is 84.68 vs. the industry median of 65.38, Sisram Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.38, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sisram Medical's current Days Sales Outstanding of 82.38 is 26% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Sisram Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sisram Medical's current Days Sales Outstanding is 82.38, which is near median its own 10-year median of 84.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sisram Medical stock overvalued right now?
Based on GuruFocus' analysis, Sisram Medical (SRAMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $1.00, compared to a current price of $0.06 — trading 94.5% below its estimated fair value. The current Days Sales Outstanding is 82.38, which is near median its 10-year median of 84.68 and 26% above the Medical Devices & Instruments industry median of 65.38. Sisram Medical's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Sisram Medical (SRAMF), the current Days Sales Outstanding is 82.38 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sisram Medical (SRAMF) Overvalued in 2026?
Based on GuruFocus' analysis, Sisram Medical stock appears to be undervalued.
The current stock price of $0.06 is trading 94.5% below its estimated GF Value™ of $1.00.
GuruFocus considers Sisram Medical to be Significantly Undervalued.
Key valuation signals for SRAMF:
Days Sales Outstanding: 82.38 (near median its 10-year median of 84.68)
GF Value™: $1.00 vs. price of $0.06 (94.5% below fair value)
Industry Position: 26% above the Medical Devices & Instruments median (#615 of 811)
No single metric tells the full story. See the SRAMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
87GF Score
Get the complete analysis for SRAMF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRAMF has been successfully added to your 
